From January 1, 2024 to March 31, 2024, the company has repurchased 1,040,000 shares, representing 1.28% for $35.65 million. With this, the company has completed the repurchase of 1,507,585 shares, representing 1.86% for $50.66 million under the buyback announced on October 26, 2023.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
32.52 USD | +0.35% |
|
+2.37% | -4.31% |
06-04 | AstraZeneca AB completed the acquisition of Fusion Pharmaceuticals Inc. from a group of shareholders. | CI |
06-03 | After trial, investors weigh Trump 2.0 factor as election looms | RE |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.31% | 2.6B | |
-5.19% | 94.23B | |
+10.82% | 26.25B | |
-7.96% | 17.25B | |
-1.45% | 14.43B | |
+2.60% | 13.64B | |
-23.36% | 12.01B | |
+23.83% | 10B | |
+17.52% | 9.11B | |
+21.40% | 6.79B |
- Stock Market
- Equities
- FHI Stock
- News Federated Hermes, Inc.
- Tranche Update on Federated Hermes, Inc.'s Equity Buyback Plan announced on October 26, 2023.